A few months ago, the father of marijuana research, Professor Raphael Mechoulam, unveiled his newest discovery: the cannabidiolic acid (EPM 301). His introduction of the latest, patented substance caused much excitement in the marijuana industry, especially within the medical cannabis sector. His compound is entirely stable, synthetic, and an acid-based cannabinoid molecule. It was announced to the world in collaboration with EPM, a global biotechnology company in America. EPM seeks to bridge the gap between the pharmaceutical industry and the cannabis market.
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…
By gently heating your plant matter instead of setting it on fire, a vaporizer extracts…
For the past five years, Texas has lived in a strange legal limbo. The 2018…
Thirty years after Prop 215, the California State Fair crowned its first home-grow champion and…
Senate leaders released a stopgap that would push most of the federal hemp deadline to…